Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers

NCT03760848 is registered in ClinicalTrials.gov with Galmed Pharmaceuticals Ltd as lead sponsor.

NCT NCT03760848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03760848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy Volunteers
Lead sponsor
Galmed Pharmaceuticals Ltd
Phase
Phase 1
Overall status
Completed
Start date
November 12, 2018
Completion date
February 2, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy